Modular Medical, Inc. (MODD) - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2025 Annual Meeting of Shareholders held on February 28, 2025. A quorum was established with approximately 74.9% of outstanding common stock represented. The filing covers the voting outcomes for three specific proposals submitted to shareholders.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
Shareholders voted on and approved the following proposals:
- Proposal 1 (Election of Directors): All seven nominees were elected to serve until the next annual meeting. Voting results varied by candidate:
- Duane DeSisto: 16,037,708 For; 4,097,829 Against.
- Paul DiPerna: 18,778,495 For; 1,357,042 Against.
- Steven Felsher: 19,363,955 For; 771,587 Against.
- Morgan Frank: 17,481,482 For; 2,654,060 Against.
- Philip Sheibley: 19,173,915 For; 961,614 Against.
- Carmen Volkart: 16,338,424 For; 3,797,100 Against.
- Ellen O'Connor Vos: 17,326,827 For; 2,810,418 Against.
- Proposal 2 (Equity Incentive Plan Amendment): Approved to increase the number of shares reserved for issuance under the Amended and Restated 2017 Equity Incentive Plan by 3,000,000 shares.
- Votes: 12,169,001 For; 7,488,354 Against; 522,723 Abstain.
- Proposal 3 (Audit Firm Ratification): Approved the appointment of Farber Hass Hurley LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2025.
- Votes: 30,401,496 For; 14,273 Against; 46,503 Abstain.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a report of shareholder voting results.
Key Facts for Investor Verification
- Verify the impact of the 3,000,000 share increase in the equity incentive plan on potential future dilution.
- Note the significant "Against" votes for certain directors (e.g., Duane DeSisto and Carmen Volkart received over 4 million and 3.7 million "Against" votes respectively), which may indicate shareholder sentiment issues.
- Confirm the appointment of Farber Hass Hurley LLP as the auditor for the fiscal year ending March 31, 2025.
- Review the definitive proxy statement filed on January 24, 2025, for detailed background on the proposals.